ESC Council for Cardiology Practice Chairperson

🫀 CVD in older adults – prevalence rises with age, along with multiple comorbidities. A new ESC EAPC & Council for Cardiology Practice consensus offers practical, evidence-based guidance on risk factor management in this population. doi.org/10.1093/eurjpc…

Dear colleague, Share your experience with the 2024 ESC Hypertension Guidelines. This <9-minute survey will help identify real-world barriers and improve care across Europe. Access the survey and add your voice. click.info.escardio.org/?qs=eyJkZWtJZC…

3 March 2026 | #CardioPractice CardioTalk 🎙️ How to implement a diagnosis of HCM in 2026 Host: Dr M. Ferrini (Lyon, FR) Speaker: Prof. W. McKenna (London, GB) Practical perspectives on translating HCM diagnostic standards into real-world practice. esc365.escardio.org/event/2595

3 March 2026 | #CardioPractice CardioTalk 🎙️ Treatment of Hypertrophic Cardiomyopathy in 2026: what are the challenges? Host: Dr T. Kumler (Herlev, DK) Speaker: Dr A. Christensen (Copenhagen, DK) Key insights into evolving HCM management. esc365.escardio.org/event/2594

New review on HCM: from decades of symptom-directed therapy and septal reduction to emerging drugs targeting the underlying molecular pathology of HCM. Mechanisms, evidence base, and future directions — now available. escardio.org/communities/co…

New CardioPractice issue: focus on HCM. Assoc. Prof. Alex Horby Christensen and colleagues review emerging agents targeting the molecular basis of HCM. Plus: exclusive video & podcast with William John McKenna escardio.org/communities/co…

🎧 New CardioPractice CardioTalk episode — HF management in patients with aortic valve stenosis Hosted by Dr Nistri, with Dr Delgado addressing therapeutic strategies, timing of intervention, and clinical complexity in this high-risk population. esc365.escardio.org/event/2573

🎙️ New CardioPractice CardioTalk episode — Assessment of asymptomatic aortic valve stenosis Hosted by Dr Nistri, with Prof. Toutouzas discussing diagnostic strategies, risk stratification, and clinical decision-making in patients without overt symptoms. esc365.escardio.org/event/2575

New in CardioPractice: key criteria for diagnosing asymptomatic aortic valve stenosis — including echo thresholds, stress testing to unmask latent symptoms, biomarkers and high-risk features that may prompt earlier intervention. escardio.org/communities/co…

This month on CardioPractice: 🫀 Prof. Bohbot explores diagnosis and management of asymptomatic aortic valve stenosis. 🎙️ Two expert discussions hosted by Dr Nistri: • with Prof. Toutouzas on what “asymptomatic” truly means • with Dr Delgado on management when HF is present

Environmental stressors and cardiovascular health: acting locally for global impact in a changing world. A statement of the @escardio, the @ACCinTouch, @American_Heart, and the @worldheartfed 👉 ow.ly/USvo50Y1IRM @RoccoMontone @ehj_ed #EHJ

New CardioPractice CardioTalk podcast — Heart failure & mental health Hosted by Dr. R. Christodorescu (CCP) with Dr. Marta Farrero Torres (Barcelona), discussing the impact of mental health conditions on HF outcomes and patient-centred management. esc365.escardio.org/event/2453?_gl…..

**New CardioPractice CardioTalk podcast — Sex & gender in mental health and CVD** Hosted by Dr. R. Christodorescu (CCP) with Prof. Hector Bueno (Madrid), exploring how sex and gender differences shape mental health conditions. esc365.escardio.org/event/2452?_gl…..

New CardioPractice CardioTalk podcast — General cardiology & cardiometabolic disease Hosted by Dr. Marc Ferrini with Prof. Cecilia Linde (Stockholm), discussing key intersections between cardiometabolic conditions and everyday practice. esc365.escardio.org/event/2451?_gl…..

New CardioPractice article | Person-centred cardio-mental care Prof. Simona Dragan (Victor Babeș University, Romania) outlines how integrated psycho-cardio teams, ACTIVE screening, stepped care, and tailored therapies can transform management of comorbid mental health and CVD.

CardioPractice Volume 37 is out! Mental health meets cardiovascular care. New issue featuring Prof. Simona Dragan on person-centred CV–mental health management, plus two expert podcasts hosted by Assoc. Prof. R. Christodorescu with Prof. Hector Bueno and Prof. Martha Farrero.

🎙️ New CardioTalk Podcast 2025 ESC Dyslipidaemia Guidelines – What’s New? Host Dr. D. Richter (Athens) and speaker Dr. K. Koskinas (Bern) break down the key novelties of the updated ESC recommendations. Tune in for expert insights from the ESC CCP. esc365.escardio.org/event/2243?_gl…..

🎙️ New CardioTalk Podcast We honour Scott Grundy, a true pioneer in lipidology whose vision shaped modern dyslipidaemia guidelines. Tune in as Prof. Neil J. Stone reflects on Grundy’s legacy. esc365.escardio.org/event/2237?_gl…..

🚨 Bempedoic acid in 2025: what’s new? CLEAR showed ~13% CV risk reduction in statin-intolerant patients. The 2025 ESC/EAS uodate: Class I for statin intolerance, Class IIa as add-on when targets aren’t met. A valuable tool—not a statin replacement. escardio.org/Councils/Counc…

🚨 New in CardioPractice! The 2025 ESC/EAS Dyslipidaemia Update is here. LDL-C targets unchanged, risk refined with SCORE2/SCORE2-OP, and earlier post-ACS intervention. Statins first-line, with Ezetimibe, PCSK9i & bempedoic acid when needed. escardio.org/Councils/Counc…